Announcements Trials
Browse Landscape

Status

Recruiting 782Active not recruiting 386Completed 295Not yet recruiting 169Terminated 85Withdrawn 25Suspended 24Enrolling by invitation 24Available 9No longer available 4Unknown 1Approved for marketing 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Expanded_access 4

Sponsor

Cancer Type

Thoracic 6Gastrointestinal 5Plasma cell 4CNS 4Sarcoma 3Other hematologic neoplasm 3Genitourinary 3Dermatologic 3Lymphoid 2Other solid neoplasm 1Myeloid 1Gynecologic 1Breast 1

Conditions

Neuroblastoma 2Glioblastoma 2Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Meningeal Neoplasms 1Medulloblastoma 1Hepatoblastoma 1Dysbiosis 1

Interventions

omburtamab I-131 1gallium maltolate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
No longer available × CNS × 1 year × Clear all
NCT06404034 2026-03-04

Expanded Access to Gallium Maltolate (GaM)

Imaging Biometrics, LLC

No longer available
CNS

Glioblastoma

NCT07223606 2025-11-03

Fecal Microbiota Transplant for Neuroblastoma in a Single Patient

ProgenaBiome

No longer available
CNS

Neuroblastoma, Dysbiosis

NCT04802447 2025-09-16

EAP

Roswell Park Cancer Institute

No longer available
CNS

Glioblastoma

NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡